Company Overview of Kedaara Capital Investment Managers Limited
Kedaara Capital Investment Managers Limited is a private equity firm specializing in buyouts, growth capital, carve-outs or spin-offs of businesses within diversified Indian family conglomerates, standalone Indian Companies, or Indian operations of multi-national companies (MNCs), and corporate divestitures of under 99-managed or non-core business units. It prefers to invest in late stages in companies. The firm seeks to invest in consumer, financial and business services, consumer durables and apparel, industrials, technology, pharmaceuticals, healthcare, agriculture, agricultural services, fertilizers and agricultural chemicals, agricultural machinery and equipment, and resources sectors. ...
Founded in 2011
Key Executives for Kedaara Capital Investment Managers Limited
Co-Founder, Founding Partner, and Managing Partner
Co-Founder and Managing Partner
Co-Founder and Managing Director
Compensation as of Fiscal Year 2015.
Kedaara Capital Investment Managers Limited Key Developments
Kedaara Capital Advisors LLP Presents at HKVCA Asia Private Equity Forum 2016, Jan-20-2016 02:00 PM
Dec 30 15
Kedaara Capital Advisors LLP Presents at HKVCA Asia Private Equity Forum 2016, Jan-20-2016 02:00 PM. Venue: Hong Kong Convention and Exhibition Centre, Hong Kong. Speakers: Nishant Sharma, Managing Director and CoFounder.
Kedaara Capital Is Reported To Buy 20% Stake In ZCL Chemicals
Oct 23 15
Kedaara Capital Investment Managers Limited is close to picking up around 20% stake in ZCL Chemicals Limited, formerly known as Zandu Chemicals Limited, for about INR 1.8 billion, two people familiar with the development told ET. "Kedaara's bid to acquire a minority stake in ZCL is the highest. A decision will be taken soon," a person involved in the deal said. Nihar Parikh, executive director of ZCL, said ZCL is in talks with PE firms to raise funds for expansion. I would not be able to comment on the firms shortlisted or the valuation at this stage," he said in an emailed response.
Carlyle, Kedaara, Others Reportedly In Talks To Buy Cosme Farma
Oct 20 15
The Carlyle Group LP (NasdaqGS:CG), Kedaara Capital Investment Managers Limited and Multiples Alternate Asset Management Private Limited are among a clutch of firms negotiating with Adcock Ingram Holdings Limited (JSE:AIP) for acquiring its loss-making India unit, COSME Farma Laboratories Ltd., according to people aware of the development. Adcock has initiated the process of selling it, they said. Some Indian drug makers including Lupin Limited (BSE:500257) are also said to be in the race for Cosme's assets. First Rand has been given the mandate to look for buyers, one of the persons cited earlier said. "The investment bankers have approached growth funds such as Kedaara, Carlyle Growth and Multiples. A couple of strategic investors too have been approached," the person said. Spokespersons for Adcock Ingram, Kedaara, Carlyle and Multiples Alternatives did not respond to Economic Times's calls or text messages for comment on the development. An email query sent to Lupin for comment did not elicit any response till press time on October 20, 2105.
Similar Private Companies By Industry
Recent Private Companies Transactions